No Data
No Data
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
Qualigen Therapeutics | 10-Q: Q3 2024 Earnings Report
Qualigen Therapeutics Appoints Graydon Bensler to Board
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Qualigen Therapeutics Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
No Data
No Data
T-24Century : 10.0 Next week